COM:CYTODYN
CytoDyn Inc.
- Stock
Last Close
0.27
01/05 20:00
Market Cap
149.26M
Beta: -
Volume Today
2.44M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
May '15 | May '16 | May '17 | May '18 | May '19 | May '20 | May '21 | May '22 | May '23 | May '24 | May '25 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -45.41K - | 9.53M 21,081.08% | 56.31M 491.03% | 55.70M 1.08% | 8.96M 83.91% | |||||||
average payables | 3.15M - | 3.74M 18.74% | 3.37M 9.82% | 10.06M 198.16% | 16.04M 59.43% | 22.86M 42.51% | 47.69M 108.62% | 66.94M 40.36% | 65.35M 2.37% | 46.14M 29.39% | 22.13M 52.05% | |
average receivables | 45.41K - | 45.41K 0% | 8.96M - | 8.96M 0% | 1M - | |||||||
book value per share | -0.18 - | 0.11 158.38% | -0.01 107.48% | -0.08 841.15% | -0.03 56.45% | -0.01 82.02% | -0.04 507.22% | -0.14 289.87% | -0.12 14.01% | -0.12 0.43% | -0.08 33.86% | |
capex per share | -0.00 - | -0.00 60.67% | -0.00 35.68% | -0.00 - | -0.00 41.37% | -0.00 112.74% | ||||||
capex to depreciation | -0.05 - | -0.03 35.89% | -0.03 8.20% | -0.04 - | -0.02 44.46% | -0.07 236.10% | ||||||
capex to operating cash flow | 0.00 - | 0.00 68.86% | 0.00 13.67% | 0.00 - | 0.00 33.44% | 0.00 73.73% | ||||||
capex to revenue | ||||||||||||
cash per share | 0.02 - | 0.10 461.64% | 0.01 87.26% | 0.01 45.27% | 0.01 36.40% | 0.03 253.13% | 0.06 70.32% | 0.01 89.18% | 0.00 55.48% | 0.01 263.78% | 0.01 2.48% | |
days of inventory on hand | 123.47K - | |||||||||||
days payables outstanding | 468.12K - | 372.06K - | 297.92K 19.93% | |||||||||
days sales outstanding | 24.60K - | -123.39 - | ||||||||||
debt to assets | 0.91 - | 0.13 - | 0.39 - | 0.30 23.01% | 0.48 58.12% | 1.26 162.36% | 3.14 148.74% | 2.70 13.88% | 1.51 43.91% | |||
debt to equity | -0.40 - | -0.96 - | -0.92 - | -6.19 569.54% | -3.02 51.21% | -0.39 87.09% | -0.32 17.03% | -0.26 20.35% | -0.28 10.51% | |||
dividend yield | 0.00 - | 0.01 - | ||||||||||
earnings yield | -0.46 - | -0.27 40.22% | -0.31 14.26% | -0.57 82.90% | -0.53 7.18% | -0.11 78.54% | -0.14 27.43% | -1.25 766.70% | -0.38 69.51% | -0.32 15.53% | 0.01 102.84% | |
enterprise value | 60.14M - | 84.75M 40.92% | 82.09M 3.14% | 83.92M 2.23% | 112.00M 33.45% | 1.25B 1,017.61% | 1.23B 1.40% | 262.71M 78.71% | 271.85M 3.48% | 174.80M 35.70% | 424.07M 142.60% | |
enterprise value over ebitda | -3.11 - | -3.97 27.71% | -3.05 23.31% | -1.82 40.10% | -2.03 11.48% | -17.04 737.84% | -13.28 22.10% | -3.27 75.34% | -4.42 35.04% | -9.70 119.32% | 49.20 607.46% | |
ev to operating cash flow | -5.00 - | -3.42 31.75% | -3.07 10.10% | -2.81 8.59% | -2.22 20.94% | -18.19 719.74% | -10.50 42.30% | -3.38 67.80% | -10.83 220.29% | -15.92 47.02% | -48.38 203.96% | |
ev to sales | 987.64 - | -71.68 - | ||||||||||
free cash flow per share | -0.21 - | -0.26 26.15% | -0.19 25.49% | -0.17 11.78% | -0.19 8.61% | -0.16 11.95% | -0.20 22.51% | -0.11 42.68% | -0.03 76.05% | -0.01 58.81% | -0.01 35.83% | |
free cash flow yield | -0.21 - | -0.26 24.37% | -0.32 22.81% | -0.35 8.71% | -0.47 35.25% | -0.06 88.41% | -0.10 77.49% | -0.34 245.63% | -0.11 68.89% | -0.07 32.37% | -0.02 69.82% | |
graham net net | -0.25 - | 0.06 125.89% | -0.05 184.24% | -0.10 79.83% | -0.10 3.74% | -0.07 30.67% | -0.12 78.09% | -0.14 16.20% | -0.13 9.58% | -0.12 5.95% | -0.08 31.44% | |
graham number | 1.35 - | 0.80 40.50% | 0.18 77.24% | 0.68 273.75% | 0.39 43.02% | 0.21 45.86% | 0.49 131.10% | 1.16 136.73% | 0.52 55.08% | 0.37 28.12% | ||
income quality | 0.48 - | 0.97 101.52% | 1.04 7.49% | 0.60 42.54% | 0.90 50.66% | 0.55 38.42% | 0.76 37.44% | 0.37 51.50% | 0.31 14.68% | 0.22 29.95% | -2.34 1,162.20% | |
intangibles to total assets | 0.56 - | 0.16 70.60% | 0.24 44.72% | 0.32 34.41% | 0.74 131.76% | 0.27 64.07% | 0.01 95.30% | 0.00 63.86% | 0 100% | 0 | 0 | |
interest coverage | -4.31 - | -5.21 20.94% | -44.60 756.56% | -8.37 81.24% | -19.57 133.97% | -4.42 77.41% | -5.41 22.27% | -1.37 74.64% | -6.01 338.40% | 0.57 109.45% | 2.33 310.44% | |
interest debt per share | 0.15 - | 0.04 71.81% | 0.01 71.58% | 0.03 159.17% | 0.04 29.93% | 0.08 87.71% | 0.14 84.12% | 0.13 6.46% | 0.05 64.98% | -0.00 103.81% | 0.03 1,616.61% | |
inventory turnover | 0.00 - | |||||||||||
invested capital | -0.40 - | -0.96 - | -0.92 - | -6.19 569.54% | -3.02 51.21% | -0.39 87.09% | -0.32 17.03% | -73.10M 22,603,635,758.70% | -52.64M 27.99% | |||
market cap | 56.92M - | 94.39M 65.84% | 82.80M 12.27% | 85.15M 2.84% | 106.37M 24.92% | 1.25B 1,075.73% | 1.20B 3.68% | 230.15M 80.89% | 238.97M 3.84% | 154.54M 35.33% | 408.63M 164.42% | |
net current asset value | -13.33M - | 7.91M 159.35% | -3.04M 138.39% | -14.74M 385.11% | -24.42M 65.70% | -16.17M 33.79% | -23.52M 45.46% | -95.14M 304.55% | -109.99M 15.61% | -117.08M 6.45% | -96.21M 17.82% | |
net debt to ebitda | -0.17 - | 0.45 371.19% | 0.03 94.11% | 0.03 0.63% | -0.10 481.75% | -0.01 85.73% | -0.32 2,077.84% | -0.41 27.74% | -0.53 31.73% | -1.12 110.23% | 1.79 259.38% | |
net income per share | -0.44 - | -0.27 39.36% | -0.19 30.68% | -0.28 48.42% | -0.21 25.46% | -0.34 63.03% | -0.30 12.05% | -0.43 43.75% | -0.10 76.53% | -0.05 48.55% | 0.00 106.04% | |
operating cash flow per share | -0.21 - | -0.26 26.29% | -0.19 25.49% | -0.17 11.74% | -0.19 8.51% | -0.16 11.92% | -0.20 22.46% | -0.11 42.62% | -0.03 76.05% | -0.01 58.81% | -0.01 35.83% | |
payables turnover | 0.00 - | 0.00 - | 0.00 24.89% | |||||||||
receivables turnover | 0.01 - | -2.96 - | ||||||||||
research and ddevelopement to revenue | 101.67 - | -2.86 - | ||||||||||
return on tangible assets | -12.57 - | -2.23 82.25% | -4.20 88.10% | -14.54 246.51% | -10.41 28.44% | -3.83 63.24% | -1.33 65.13% | -9.92 643.40% | -8.08 18.54% | -4.48 44.61% | 0.21 104.64% | |
revenue per share | 0.00 - | -0.00 - | ||||||||||
roe | 2.42 - | -2.52 203.87% | 23.35 1,027.21% | 3.68 84.23% | 6.30 71.15% | 57.16 806.84% | 8.28 85.52% | 3.05 63.13% | 0.83 72.71% | 0.43 48.77% | -0.04 109.13% | |
roic | 3.15 - | -2.07 165.62% | 561.02 27,204.02% | 3.37 99.40% | 78.96 2,241.53% | -6.52 108.26% | -2.73 58.20% | 1.72 163.23% | 0.64 62.90% | 0.21 67.41% | -0.45 316.31% | |
sales general and administrative to revenue | 166.55 - | -1.23 - | ||||||||||
shareholders equity per share | -0.18 - | 0.11 158.38% | -0.01 107.48% | -0.08 841.15% | -0.03 56.45% | -0.01 82.02% | -0.04 507.22% | -0.14 289.87% | -0.12 14.01% | -0.12 0.43% | -0.08 33.86% | |
stock based compensation to revenue | 23.45 - | -0.27 - | ||||||||||
tangible asset value | -13.31M - | 7.94M 159.64% | -3.02M 138.05% | -14.73M 387.51% | -24.39M 65.63% | -15.94M 34.66% | -22.67M 42.26% | -94.53M 316.96% | -109.50M 15.84% | -116.76M 6.63% | -96.04M 17.74% | |
tangible book value per share | -0.23 - | 0.08 136.48% | -0.02 126.31% | -0.08 284.70% | -0.09 6.48% | -0.04 57.79% | -0.04 1.95% | -0.14 261.95% | -0.12 14.13% | -0.12 0.43% | -0.08 33.86% | |
working capital | -8.69M - | 7.91M 191.09% | -23.07K 100.29% | -13.41M 58,046.31% | -21.56M 60.72% | -7.67M 64.40% | -22.96M 199.27% | -94.72M 312.44% | -108.99M 15.07% | -73.37M 32.69% | -52.64M 28.25% |
All numbers in (except ratios and percentages)